Skip to main content
Clinical Trials/NCT06027515
NCT06027515
Completed
Not Applicable

A Multimodal Prehabilitation Feasibility Study for Older Adult Patients at High Risk for Poor Postoperative Outcomes Prior to Esophageal Cancer Surgery

Massachusetts General Hospital1 site in 1 country15 target enrollmentDecember 1, 2023

Overview

Phase
Not Applicable
Intervention
Prehabilitation Program
Conditions
Esophageal Cancer
Sponsor
Massachusetts General Hospital
Enrollment
15
Locations
1
Primary Endpoint
Enrollment Rate (Feasibility)
Status
Completed
Last Updated
2 months ago

Overview

Brief Summary

The goal of this research study is to investigate the feasibility of implementing a prehabilitation program that aims to improve a patient's physical, nutritional, and sleep health before surgery in an older, at-risk group with esophageal cancer.

Detailed Description

This research study is to test whether a novel, 4-week surgical multimodal prehabilitation protocol is feasible in at-risk older adult patients who have previously undergone neoadjuvant chemotherapy or radiotherapy and are scheduled for surgical removal of esophageal cancer. Research study procedures include screening for eligibility, clinic visits, questionnaires, blood tests, and Computed Tomography (CT) scans. Participation in this research study is expected to last 7 months. It is expected about 30 patients will participate in this study.

Registry
clinicaltrials.gov
Start Date
December 1, 2023
End Date
January 31, 2026
Last Updated
2 months ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Hassan Dashti

Principal Investigator

Massachusetts General Hospital

Eligibility Criteria

Inclusion Criteria

  • 65 years of age and over
  • Adult male or non-pregnant female volunteers
  • Completed neoadjuvant chemotherapy or radiotherapy for esophageal cancer
  • At least four weeks to esophageal cancer surgery
  • Without skin conditions that preclude wearing sensors
  • Able to speak English and consent

Exclusion Criteria

  • Participants in any other interventional study that may bias results or limit study adherence during our study
  • Dietary restrictions that prevent consumption of nutritional supplements
  • Women who are pregnant, nursing, or at risk of becoming pregnant
  • Profound physical disability (for example, quadriplegia) that precludes participation in any aerobic or strength training.

Arms & Interventions

Prehabilitation Program

30 participants will be enrolled and will complete study procedures as follows: * Enrollment at least 4 weeks prior to esophageal cancer surgery. * In-person clinic visit with dietitian and physical therapist for assessments, and completion of baseline questionnaires with study coordinator. * Adherence to daily physical function, dietary, and sleep recommendations and consumption of 5-day immunonutrition supplement. * Regular electronic/phone-call check-ins with study staff. * Telehealth appointment with physical therapist and dietitian prior to surgery. * After surgery and during hospital admission, final visit with dietitian and physical therapist for assessments, and completion of questionnaires. * 6-month follow-up period.

Intervention: Prehabilitation Program

Outcomes

Primary Outcomes

Enrollment Rate (Feasibility)

Time Frame: At screening

Number of eligible patients who enroll in study

Completion Rate (Feasibility)

Time Frame: 30 days

Defined as the number of patients who complete study procedures.

Secondary Outcomes

  • Sleep Health Compliance Rate (Feasibility)(30 days)
  • Nutrition Compliance Rate (Feasibility)(5 days)
  • Physical Function Compliance Rate (Feasibility)(30 days)
  • Actigraphy Compliance Rate (Feasibility)(30 days)

Study Sites (1)

Loading locations...

Similar Trials